GSK - 36 Year Stock Price History | GSK

Historical daily share price chart and data for GSK since 1986 adjusted for splits. The latest closing stock price for GSK as of September 23, 2022 is 29.36.
  • The all-time high GSK stock closing price was 57.45 on April 13, 2022.
  • The GSK 52-week high stock price is 58.71, which is 100% above the current share price.
  • The GSK 52-week low stock price is 29.09, which is 0.9% below the current share price.
  • The average GSK stock price for the last 52 weeks is 50.20.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
GSK Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 48.7213 52.7786 57.4515 29.3600 29.3600 -44.91%
2021 46.1748 43.1168 53.7092 39.1030 53.2983 26.77%
2020 44.6627 50.9805 52.0344 35.0652 42.0429 -17.65%
2019 44.0584 39.1796 51.4151 39.1279 51.0566 29.19%
2018 39.7970 36.1879 43.3065 34.7769 39.5209 13.71%
2017 38.3649 36.1230 42.3258 33.9636 34.7573 -2.96%
2016 37.5718 35.2677 41.3810 33.9163 35.8161 1.81%
2015 36.7631 35.0002 40.9127 32.3148 35.1805 -0.35%
2014 40.5949 41.4031 44.8534 34.1163 35.3058 -15.68%
2013 38.2730 32.9781 41.8736 32.8287 41.8736 28.90%
2012 32.9327 32.7293 34.9759 30.9260 32.4849 0.67%
2011 28.8063 26.3408 32.3474 24.3811 32.2697 22.60%
2010 24.9801 27.3366 27.7348 21.1543 26.3206 -2.08%
2009 22.6754 22.3493 27.2984 16.7151 26.8785 19.30%
2008 25.4818 28.8588 31.2690 19.3569 22.5306 -22.27%
2007 30.2234 29.8109 33.1908 27.5358 28.9854 -0.83%
2006 29.3752 27.3338 31.8296 26.8993 29.2292 7.95%
2005 25.8564 24.6240 28.7123 23.1315 27.0763 9.87%
2004 21.7345 23.4539 24.7020 19.9640 24.6448 5.55%
2003 20.0049 18.6354 23.7394 16.0497 23.3487 28.80%
2002 20.3304 23.4217 23.9010 15.6490 18.1273 -22.56%
2001 25.0090 25.8471 26.9291 22.5723 23.4076 -9.63%
2000 25.2976 24.5133 28.4879 20.2954 25.9026 5.06%
1999 25.6850 30.3138 32.2880 21.2512 24.6545 -16.98%
1998 24.8435 20.1821 29.6985 20.1821 29.6985 47.92%
1997 16.5942 12.9416 20.1276 12.4259 20.0772 53.28%
1996 11.4226 11.1823 14.0266 9.4734 13.0984 17.14%
1995 9.2391 7.9344 11.1823 7.2235 11.1823 44.39%
1994 6.8942 7.6606 8.0789 5.8857 7.7443 2.30%
1993 6.7018 8.3409 8.3409 5.2625 7.5699 -8.79%
1992 9.4031 10.8946 11.8791 7.7748 8.2990 -23.54%
1991 7.4656 5.4791 10.8536 5.1858 10.8536 98.87%
1990 4.6100 4.1450 5.7707 3.6814 5.4575 30.40%
1989 3.6213 3.0167 4.2448 2.8992 4.1853 38.74%
1988 2.7787 2.8782 3.1530 2.4600 3.0167 8.37%
1987 3.5902 2.2992 4.5564 2.2992 2.7836 21.07%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $59.709B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.984B 9.16
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.873B 0.00
QIAGEN (QGEN) Netherlands $9.383B 15.71
Ginkgo Bioworks Holdings (DNA) United States $4.998B 0.00
Arcus Biosciences (RCUS) United States $1.819B 35.51
Myovant Sciences (MYOV) United Kingdom $1.614B 0.00
Emergent Biosolutions (EBS) United States $1.040B 6.03
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.305B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Gelesis Holdings (GLS) United States $0.081B 0.00
SQZ Biotechnologies (SQZ) United States $0.068B 0.00
Ambrx Biopharma (AMAM) United States $0.041B 0.00